284 related articles for article (PubMed ID: 29058342)
41. Normal Tissue Complication Probability Model for Radiation-induced Temporal Lobe Injury after Intensity-modulated Radiation Therapy for Nasopharyngeal Carcinoma.
Zeng L; Huang SM; Tian YM; Sun XM; Han F; Lu TX; Deng XW
Radiology; 2015 Jul; 276(1):243-9. PubMed ID: 25658039
[TBL] [Abstract][Full Text] [Related]
42. Functional experiential hallucinosis after radiotherapy for nasopharyngeal carcinoma.
Lam LC; Leung SF; Chow LY
J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):259-61. PubMed ID: 9489544
[TBL] [Abstract][Full Text] [Related]
43. Radiation-induced brachial plexopathy in patients with nasopharyngeal carcinoma: a retrospective study.
Cai Z; Li Y; Hu Z; Fu R; Rong X; Wu R; Cheng J; Huang X; Luo J; Tang Y
Oncotarget; 2016 Apr; 7(14):18887-95. PubMed ID: 26934119
[TBL] [Abstract][Full Text] [Related]
44. Neurosurgery and prognosis in patients with radiation-induced brain injury after nasopharyngeal carcinoma radiotherapy: a follow-up study.
Li Y; Shi X; Rong X; Peng Y; Tang Y
Radiat Oncol; 2013 Apr; 8():88. PubMed ID: 23578338
[TBL] [Abstract][Full Text] [Related]
45. Changes in brain gray matter volume in nasopharyngeal carcinoma patients after radiotherapy in long-term follow-up.
Zhu W; Chen F; Yin D; Chen K; Wang S
Braz J Otorhinolaryngol; 2023; 89(3):477-484. PubMed ID: 36805347
[TBL] [Abstract][Full Text] [Related]
46. Late temporal lobe necrosis in patients with nasopharyngeal carcinoma: evaluation with combined multi-section diffusion weighted and perfusion weighted MR imaging.
Tsui EY; Chan JH; Ramsey RG; Leung TW; Cheung YK; Luk SH; Lai KF; Wong KP; Fong D; Yuen MK
Eur J Radiol; 2001 Sep; 39(3):133-8. PubMed ID: 11566238
[TBL] [Abstract][Full Text] [Related]
47. Longitudinal study of irradiation-induced brain functional network alterations in patients with nasopharyngeal carcinoma.
Fu G; Xie Y; Pan J; Qiu Y; He H; Li Z; Li J; Feng Y; Lv X
Radiother Oncol; 2022 Aug; 173():277-284. PubMed ID: 35718009
[TBL] [Abstract][Full Text] [Related]
48. Stereotactic radiotherapy following surgery for brain metastasis: Predictive factors for local control and radionecrosis.
Doré M; Martin S; Delpon G; Clément K; Campion L; Thillays F
Cancer Radiother; 2017 Feb; 21(1):4-9. PubMed ID: 27955888
[TBL] [Abstract][Full Text] [Related]
49. Temporal lobe injury patterns following intensity modulated radiotherapy in a large cohort of nasopharyngeal carcinoma patients.
Lu L; Sheng Y; Zhang G; Li Y; OuYang PY; Ge Y; Xie T; Chang H; Deng X; Wu JQ
Oral Oncol; 2018 Oct; 85():8-14. PubMed ID: 30220323
[TBL] [Abstract][Full Text] [Related]
50. Asymptomatic temporal lobe injury after radiotherapy for nasopharyngeal carcinoma: incidence and determinants.
Leung SF; Kreel L; Tsao SY
Br J Radiol; 1992 Aug; 65(776):710-4. PubMed ID: 1393399
[TBL] [Abstract][Full Text] [Related]
51. Analysis of late toxicity in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy.
Zheng Y; Han F; Xiao W; Xiang Y; Lu L; Deng X; Cui N; Zhao C
Radiat Oncol; 2015 Jan; 10():17. PubMed ID: 25582731
[TBL] [Abstract][Full Text] [Related]
52. [Diagnostic value of MR diffusion tensor imaging on radiation-induced early brain injury of nasopharyngeal carcinoma after radiotherapy].
Tan XP; Zhao JQ; Liang BL; Xie BK; Zhong JL; Ye RX
Ai Zheng; 2004 Nov; 23(11):1334-7. PubMed ID: 15522185
[TBL] [Abstract][Full Text] [Related]
53. Functional integrity in children with anoxic brain injury from drowning.
Ishaque M; Manning JH; Woolsey MD; Franklin CG; Tullis EW; Beckmann CF; Fox PT
Hum Brain Mapp; 2017 Oct; 38(10):4813-4831. PubMed ID: 28759710
[TBL] [Abstract][Full Text] [Related]
54. Eustachian tube dysfunction in patients with nasopharyngeal carcinoma, pre- and post-irradiation.
Young YH; Hsieh T
Eur Arch Otorhinolaryngol; 1992; 249(4):206-8. PubMed ID: 1642877
[TBL] [Abstract][Full Text] [Related]
55. Preliminary results of a phase I/II study of simultaneous boost irradiation radiotherapy for locally advanced nasopharyngeal carcinoma.
Xiang L; Wang Y; Xu BQ; Wu JB; Xia YF
Asian Pac J Cancer Prev; 2013; 14(12):7569-76. PubMed ID: 24460335
[TBL] [Abstract][Full Text] [Related]
56. Bevacizumab reverses cerebral radiation necrosis.
Wong ET; Huberman M; Lu XQ; Mahadevan A
J Clin Oncol; 2008 Dec; 26(34):5649-50. PubMed ID: 18981459
[No Abstract] [Full Text] [Related]
57. MRI-based brain structural changes following radiotherapy of Nasopharyngeal Carcinoma: A systematic review.
Voon NS; Lau FN; Zakaria R; Md Rani SA; Ismail F; Manan HA; Yahya N
Cancer Radiother; 2021 Feb; 25(1):62-71. PubMed ID: 33414057
[TBL] [Abstract][Full Text] [Related]
58. Recurrent cystic radiation necrosis of the brain.
Wong ET
Oncol Rep; 1998; 5(3):685-7. PubMed ID: 9538176
[TBL] [Abstract][Full Text] [Related]
59. Clinical treatment considerations in the intensity-modulated radiotherapy era for patients with N0-category nasopharyngeal carcinoma and enlarged neck lymph nodes.
Peng H; Chen L; Guo R; Zhang Y; Li WF; Mao YP; Sun Y; Zhang F; Liu LZ; Tian L; Ma J
Chin J Cancer; 2017 Mar; 36(1):32. PubMed ID: 28340596
[TBL] [Abstract][Full Text] [Related]
60. Early changes of brain connectivity in primary open angle glaucoma.
Frezzotti P; Giorgio A; Toto F; De Leucio A; De Stefano N
Hum Brain Mapp; 2016 Dec; 37(12):4581-4596. PubMed ID: 27503699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
